This inventor holds 1 USPTO granted patent. Top assignees: National Cancer Center, Rational Drug Design Laboratories. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 264 
1 out of 6 Years Active: 1998
Title: The Innovations of Torahiko Tanaka
Introduction: Torahiko Tanaka is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of virology, particularly in the study of hepatitis C virus (HCV). His work has paved the way for advancements in the detection and treatment of this virus.
Latest Patents: Tanaka holds a patent for a nucleic acid of C type hepatitis virus derivation and process for detection. The objective of this invention is to clarify the sequence of the 3'-end site of the HCV genome and to provide a new process for detecting HCV. A new sequence with a highly conserved 3'-end site of the HCV genome has been found. Using these sequences, new processes for detecting HCV and inhibiting its proliferation have been developed. He has 1 patent to his name.
Career Highlights: Throughout his career, Tanaka has worked with notable organizations such as Rational Drug Design Laboratories and the National Cancer Center. His research has significantly impacted the understanding and management of hepatitis C.
Collaborations: Tanaka has collaborated with esteemed colleagues, including Kunitada Shimotohno and Nobuyuki Katoh. Their joint efforts have contributed to the advancement of research in the field of virology.
Conclusion: Torahiko Tanaka's innovative work in the field of hepatitis C research has made a lasting impact on medical science. His contributions continue to influence the development of effective detection and treatment methods for HCV.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile